Apollo Endosurgery, Inc.: Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates

Revenue expected between $16.0 million and $16.4 millionThird consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30%Submitted a De Novo 510(k) Classification Request to FDA

Related Keywords

Texas ,United States ,Perik Wilson ,Matt Kreps ,Jeff Black ,Barham Abu Dayyeh ,Chas Mckhann ,Apollo Endosurgery ,Exchange Commission ,Apollo Endosurgery Inc ,Company De Novo ,Drug Administration ,International Federation For The Surgery Of Obesity ,Darrow Associates Investor Relations ,University Of Texas At Houston ,Classification Request ,Unaudited Third Quarter ,Classification Request Submitted ,Endoscopic Suturing System ,Surgical Disruptive Technologies Summit ,Interventional Trial ,Mayo Clinic ,International Federation ,Metabolic Disorders ,Endoscopic Helix Tacking System ,Nasdaq Global Market ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,Apollo ,Endosurgery ,Nnounces ,Reliminary ,Third ,Quarter ,021 ,Financial ,Results ,Rovides ,Business ,Updates ,